Skip to main navigation Skip to search Skip to main content

Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

In Pakistan, Plasmodium vivax contributes to major malaria burden. In this case, a pregnant woman presented with P. vivax infection and which was not cleared by chloroquine, despite adequate treatment. This is probably the first confirmed case of chloroquine-resistant vivax from Pakistan, where severe malaria due to P. vivax is already an emerging problem.

Original languageEnglish (US)
Article number146
JournalMalaria Journal
Volume14
Issue number1
DOIs
Publication statusPublished - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Artemisinin combination therapy
  • Chloroquine resistance
  • Malaria

Fingerprint

Dive into the research topics of 'Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat'. Together they form a unique fingerprint.

Cite this